WHP Be gone Flatulence

Manufacturer: Washington Homeopathic Products
Effective date: 2014-05-08
Label type: HUMAN OTC DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-06-01 02:08:49

Label at a glance#

ProductWHP Be gone Flatulence TM

Active ingredientFERULA ASSA-FOETIDA RESIN, STRYCHNOS IGNATII SEED, NUTMEG

Label structure8 sections

Indications and uses

Relieves the symptoms of flatulence that includes gas, sour stomach, and heartburn. May include abdominal discomfort and bloating accompanied with frequent passing of gas.

Dosage and administration

Adults: 2 pills every 3 hours for 2 days. Then 2 pills morning and night for 2 weeks. Children: 1 pill. Repeat as necessary.

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

ASAFOETIDA

IGNATIA

NUX MOSCH

USES

OTC - PURPOSE SECTION

Relieves the symptoms of flatulence that includes gas, sour stomach, and heartburn. May include abdominal discomfort and bloating accompanied with frequent passing of gas.

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

As wtih all medications, keep out of reach of children.

INDICATIONS

INDICATIONS & USAGE SECTION

Indications:

Asafoetida 6c –offensive odor*

Ignatia 6c –much flatulence*

Nux mosch 6c –indigestion/bloating*

■ Bloating* ■ Gas* ■ Sour stomach* ■ Heartburn*

*These statements have not been reviewed by the Food and Drug Administration.

STOP USE AND ASK DOCTOR

WARNINGS SECTION

If symptoms persist or recur, discontinue use. If pregnant or nursing a baby, consult a licensed practitioner before using this product.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Adults: 2 pills every 3 hours for 2 days. Then 2 pills morning and night for 2 weeks.

Children: 1 pill. Repeat as necessary.

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Sucrose/Lactose Pills

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image of label

image of box

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
68428-746-29	2025-01-30	C162847	48780-1	2cef2736-91ce-d83d-e063-dadaa90ab31f	DRUG FACTS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
68428-746-14	WHP Be gone FlatulenceTM	300 in 1 BOTTLE, PLASTIC	PELLET	300		1
68428-746-29	WHP Be gone FlatulenceTM	1 in 1 PACKAGE	PELLET	1		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
68428-746	WHP BE GONE FLATULENCE TM (FERULA ASSA-FOETIDA RESIN, STRYCHNOS IGNATII SEED, NUTMEG) PELLET [WASHINGTON HOMEOPATHIC PRODUCTS]	1	Legacy NDC, 2 package rows	20170609_ddfe486f-0d16-4a9f-af3f-7653ea1363bf.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

WHP Be gone Flatulence TM
FERULA ASSA-FOETIDA RESIN, STRYCHNOS IGNATII SEED, NUTMEG
FERULA ASSA-FOETIDA RESIN
ASAFETIDA
SUCROSE
LACTOSE
STRYCHNOS IGNATII SEED
NUTMEG

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
68428-746	68428-746-14, 68428-746-29

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
FERULA ASSA-FOETIDA RESIN	W9FZA51AS1	ACTIB
SUCROSE	C151H8M554	IACT
LACTOSE	J2B2A4N98G	IACT
STRYCHNOS IGNATII SEED	1NM3M2487K	ACTIB
NUTMEG	AEE24M3MQ9	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
cbd2b212-d2ea-4eb7-9ba3-6e5c80fe9d72			ddfe486f-0d16-4a9f-af3f-7653ea1363bf	2014-05-08	Warnings	Exact identifier spl id: cbd2b212-d2ea-4eb7-9ba3-6e5c80fe9d72 spl set id: ddfe486f-0d16-4a9f-af3f-7653ea1363bf

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.